UCSF scientists Elissa Epel, PhD, and Elizabeth Blackburn, PhD, are featured in a piece scheduled to air tonight, Friday, Aug. 26 at 8 p.m. on CBS 60 Minutes II.
In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.
Junior faculty and fellow candidates must submit a letter of intent by Monday, Nov. 14 to apply for a career development program for clinical and translational research.
UCSF is poised to expand its community of scientists studying alcohol addiction with the recent appointments of three endowed chairs and the recruitment of two others.